High-Response First-Line Therapies Signal Momentum in Gyn Cancers
Emerging options show strong tumor responses in advanced endometrial/ovarian cancers:
- Cadonilimab + chemo hits 78% ORR (DCR 97.6%) as first-line for...
Explore the latest tracked content in Health
Emerging options show strong tumor responses in advanced endometrial/ovarian cancers:
Expert Tom Powles spotlights 4 global Phase III trials testing novel ADCs in urothelial cancer, potentially shifting 2nd/3rd-line standards:
-...
Landmark trials redefine lung cancer care with practice-changing OS data:
New hope for late-stage prostate cancer: Phase III trial shows deutenzalutamide significantly cuts rPFS risk by 42% (HR 0.58, P=0.0001) in patients...
Public safety accountability hit: Off-duty Detroit FF Travis Turner, 26, charged with OWI causing death and firearm possession while intoxicated after...
Practical tolerance-building tips for clinical use:
Board-certified dermatologist Mamina Turegano spotlights these internal boosters for beauty routines:
Further understanding of skin microbiota mechanisms promises to clarify its role in acne pathogenesis and inspire innovative treatments.
Niacinamide, a vitamin B3 derivative, works for all skin types including sensitive skin prone to irritation. Apply 2-3 drops of 5-10% serum twice daily for easy protocols.